Aligned with this, we previously reported the genomic amplification of RAF1 in MEKi-resistant MPNST models where transcriptional upregulation of PDGFRß drives acquired resistance (Wang et al. 2021). The gene discussed is PDGFRB; the disease is malignant peripheral nerve sheath tumor.